• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞内葡萄糖神经酰胺水平的升高导致培养神经元内质网密度增加以及功能性钙储备增加。

Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons.

作者信息

Korkotian E, Schwarz A, Pelled D, Schwarzmann G, Segal M, Futerman A H

机构信息

Department of Neurobiology, The Weizmann Institute of Science, Rehovot 76100, Israel.

出版信息

J Biol Chem. 1999 Jul 30;274(31):21673-8. doi: 10.1074/jbc.274.31.21673.

DOI:10.1074/jbc.274.31.21673
PMID:10419477
Abstract

Gaucher disease is a glycosphingolipid storage disease caused by defects in the activity of the lysosomal hydrolase, glucocerebrosidase (GlcCerase), resulting in accumulation of glucocerebroside (glucosylceramide, GlcCer) in lysosomes. The acute neuronopathic type of the disease is characterized by severe loss of neurons in the central nervous system, suggesting that a neurotoxic agent might be responsible for cellular disruption and neuronal death. We now demonstrate that upon incubation with a chemical inhibitor of GlcCerase, conduritol-B-epoxide (CBE), cultured hippocampal neurons accumulate GlcCer. Surprisingly, increased levels of tubular endoplasmic reticulum elements, an increase in Ca(2+) response to glutamate, and a large increase in Ca(2+) release from the endoplasmic reticulum in response to caffeine were detected in these cells. There was a direct relationship between these effects and GlcCer accumulation since co-incubation with CBE and an inhibitor of glycosphingolipid synthesis, fumonisin B(1), completely antagonized the effects of CBE. Similar effects on endoplasmic reticulum morphology and Ca(2+) stores were observed upon incubation with a short-acyl chain, nonhydrolyzable analogue of GlcCer, C(8)-glucosylthioceramide. Finally, neurons with elevated GlcCer levels were much more sensitive to the neurotoxic effects of high concentrations of glutamate than control cells; moreover, this enhanced toxicity was blocked by pre-incubation with ryanodine, suggesting that Ca(2+) release from ryanodine-sensitive intracellular stores can induce neuronal cell death, at least in neurons with elevated GlcCer levels. These results may provide a molecular mechanism to explain neuronal dysfunction and cell death in neuronopathic forms of Gaucher disease.

摘要

戈谢病是一种糖鞘脂贮积病,由溶酶体水解酶葡萄糖脑苷脂酶(GlcCerase)活性缺陷引起,导致葡萄糖脑苷脂(葡糖神经酰胺,GlcCer)在溶酶体中蓄积。该疾病的急性神经病变型的特征是中枢神经系统中神经元严重缺失,这表明一种神经毒性剂可能是细胞破坏和神经元死亡的原因。我们现在证明,在用葡萄糖脑苷脂酶的化学抑制剂环多醇 - B - 环氧化物(CBE)孵育后,培养的海马神经元会蓄积GlcCer。令人惊讶的是,在这些细胞中检测到管状内质网元件水平增加、对谷氨酸的Ca(2 +)反应增加以及对咖啡因的反应中内质网Ca(2 +)释放大幅增加。这些效应与GlcCer蓄积之间存在直接关系,因为与CBE和糖鞘脂合成抑制剂伏马菌素B(1)共同孵育可完全拮抗CBE的效应。在用短酰基链、不可水解的GlcCer类似物C(8)-葡糖硫代神经酰胺孵育后,观察到对内质网形态和Ca(2 +)储存有类似的影响。最后,GlcCer水平升高的神经元对高浓度谷氨酸的神经毒性作用比对照细胞敏感得多;此外,这种增强的毒性可被用ryanodine预孵育阻断,这表明从ryanodine敏感的细胞内储存中释放Ca(2 +)可诱导神经元细胞死亡,至少在GlcCer水平升高的神经元中如此。这些结果可能提供一种分子机制来解释戈谢病神经病变型中的神经元功能障碍和细胞死亡。

相似文献

1
Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons.细胞内葡萄糖神经酰胺水平的升高导致培养神经元内质网密度增加以及功能性钙储备增加。
J Biol Chem. 1999 Jul 30;274(31):21673-8. doi: 10.1074/jbc.274.31.21673.
2
The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase.葡糖脑苷脂升高的神经元对神经毒性剂敏感性增加的情况可被伊米苷酶逆转。
J Inherit Metab Dis. 2000 Mar;23(2):175-84. doi: 10.1023/a:1005622001239.
3
Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.在戈谢病的神经元模型中,由于葡糖神经酰胺直接激活CTP:磷酸胆碱胞苷转移酶,磷脂酰胆碱的合成增加。
FASEB J. 2002 Nov;16(13):1814-6. doi: 10.1096/fj.02-0149fje. Epub 2002 Sep 5.
4
In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.神经母细胞瘤细胞中葡萄糖脑苷脂的体外积累:戈谢病病理生物学研究模型
J Neurosci Res. 1996 Feb 1;43(3):365-71. doi: 10.1002/(SICI)1097-4547(19960201)43:3<365::AID-JNR11>3.0.CO;2-4.
5
Neuregulin beta1 enhances peak glutamate-induced intracellular calcium levels through endoplasmic reticulum calcium release in cultured hippocampal neurons.神经调节蛋白β1 通过内质网钙释放增强培养海马神经元中峰谷氨酸诱导的细胞内钙水平。
Can J Physiol Pharmacol. 2009 Oct;87(10):883-91. doi: 10.1139/Y09-082.
6
Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages.培养的巨噬细胞中诱导的葡萄糖脑苷脂酶缺乏和葡萄糖脑苷脂的溶酶体储存。
Exp Cell Res. 1987 Feb;168(2):463-74. doi: 10.1016/0014-4827(87)90019-x.
7
Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease.采用液相色谱-串联质谱法对葡萄糖神经酰胺和葡萄糖神经鞘氨醇进行定量分析,为神经病变型戈谢病的体内临床前研究提供支持。
Anal Chem. 2017 Aug 15;89(16):8288-8295. doi: 10.1021/acs.analchem.7b01442. Epub 2017 Jul 26.
8
Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease.使用N-(1-[¹⁴C]己酰基)-D-赤型葡糖基神经鞘氨醇分析葡萄糖脑苷脂酶活性,结果显示残余酶活性水平与戈谢病类型之间存在相关性。
Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):377-82. doi: 10.1042/bj3030377.
9
Enhanced calcium release in the acute neuronopathic form of Gaucher disease.戈谢病急性神经元病变型中钙释放增强。
Neurobiol Dis. 2005 Feb;18(1):83-8. doi: 10.1016/j.nbd.2004.09.004.
10
Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons.内质网钙库的破坏参与了培养海马神经元中糖酵解抑制诱导的神经元死亡。
J Neurosci Res. 2005 Oct 15;82(2):196-205. doi: 10.1002/jnr.20631.

引用本文的文献

1
Mature neurons from iPSCs unveil neurodegeneration-related pathways in mucopolysaccharidosis type II: GSK-3β inhibition for therapeutic potential.iPSC 来源的成熟神经元揭示黏多糖贮积症 II 型相关神经退行性变通路:GSK-3β 抑制的治疗潜力。
Cell Death Dis. 2024 Apr 29;15(4):302. doi: 10.1038/s41419-024-06692-9.
2
Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology.神秘的鞘脂类:病理生理学核心的代谢相互关系
Front Physiol. 2024 Jan 3;14:1229108. doi: 10.3389/fphys.2023.1229108. eCollection 2023.
3
Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease.
基于神经祖细胞的代谢组学研究揭示了脂质代谢的失调,并确定了 CLN6 疾病的潜在生物标志物。
Sci Rep. 2023 Oct 29;13(1):18550. doi: 10.1038/s41598-023-45789-7.
4
Axonal Transport of Lysosomes Is Unaffected in Glucocerebrosidase-Inhibited iPSC-Derived Forebrain Neurons.溶酶体的轴突运输在葡糖脑苷脂酶抑制的 iPSC 衍生的前脑神经元中不受影响。
eNeuro. 2023 Oct 10;10(10). doi: 10.1523/ENEURO.0079-23.2023. Print 2023 Oct.
5
Glycosphingolipids are linked to elevated neurotransmission and neurodegeneration in a Drosophila model of Niemann Pick type C.鞘糖脂与尼曼-皮克 C 型果蝇模型中神经传递和神经退行性变的升高有关。
Dis Model Mech. 2023 Oct 1;16(10). doi: 10.1242/dmm.050206. Epub 2023 Oct 12.
6
Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson's disease.神经丝轻链作为帕金森病中LRRK2突变与痴呆之间的介导因子。
NPJ Parkinsons Dis. 2023 Sep 12;9(1):132. doi: 10.1038/s41531-023-00572-3.
7
Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology.由葡糖脑苷脂酶缺乏引起的溶酶体脂质改变会促进溶酶体功能障碍、伴侣蛋白介导的自噬缺陷以及α-突触核蛋白病变。
NPJ Parkinsons Dis. 2022 Oct 6;8(1):126. doi: 10.1038/s41531-022-00397-6.
8
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.神经元型戈谢病:超越溶酶体功能障碍
Front Mol Neurosci. 2022 Aug 3;15:934820. doi: 10.3389/fnmol.2022.934820. eCollection 2022.
9
WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson's Disease Monocytes.WHOPPA可对帕金森病单核细胞中的富含亮氨酸重复激酶2和葡萄糖脑苷脂酶的酶活性进行平行评估。
Front Cell Neurosci. 2022 Jun 9;16:892899. doi: 10.3389/fncel.2022.892899. eCollection 2022.
10
Variants and Parkinson Disease: Mechanisms and Treatments.变异与帕金森病:机制与治疗。
Cells. 2022 Apr 8;11(8):1261. doi: 10.3390/cells11081261.